IDEAYA Advances First in Class PARG Development Candidate, IDE161, into IND Enabling Studies and Exercises Option with Cancer Research UK and University of Manchester for Exclusive Worldwide License
Monday, January 31, 2022 1 min read
Key Takeaway: IDEAYA Advances First in Class PARG Development Candidate, IDE161, into IND Enabling Studies and Exercises Option with Cancer Research UK and University of Manchester for Exclusive Worldwide License
Full Press Release Details
IDEAYA Advances First in Class PARG Development Candidate, IDE161, into IND Enabling Studies and Exercises Option with Cancer Research UK and University of Manchester for Exclusive Worldwide License.